Daisuke Sueta

4.4k citations
128 papers · 2.3k · 1 hit paper · h-index 27

Impact in

    • Cardiovascular Function and Risk Factors
    • Heart Failure Treatment and Management
    • Blood Pressure and Hypertension Studies
    • Renin-Angiotensin System Studies
  • Neurology top 5%
    • Neurological Disease Mechanisms and Treatments
    • Neuroinflammation and Neurodegeneration Mechanisms

Papers in

    • Cardiovascular Function and Risk Factors 13
    • Atrial Fibrillation Management and Outcomes 10
    • Chemotherapy-induced cardiotoxicity and mitigation 9
    • Heart Failure Treatment and Management 6
    • Coronary Interventions and Diagnostics 7

Daisuke Sueta

119 papers receiving 2.3k citations

Daisuke Sueta's Hit Papers

Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice 2014 · 346 citations
3460+4+8Years since publication100200300

Peers

Daisuke Sueta
Comparison fields: 5 of 104
  • Cardiology and Cardiovascular Medicine 782
  • Neurology 231
  • Endocrinology, Diabetes and Metabolism 433
  • Internal Medicine 82
  • Nephrology 91
Replace Eiichiro Yamamoto with:
Eiichiro Yamamoto Japan
Masaaki Miyata Japan
Marek Postuła Poland
Tomohiro Osanai Japan
Richard M. Cubbon United Kingdom
Carmine Savoia Italy
C Ratnatunga United Kingdom
Toshihiko Inukai Japan
Carolina De Ciuceis Italy
Xinxue Liao China
Daisuke Sueta relative to Eiichiro Yamamoto Japan Eiichiro Yamamoto's profile →
Citations per field
00.5×1.5×
Eiichiro Yamamoto · 1×
Citations per year

Countries citing papers authored by Daisuke Sueta

Since Specialization
Citations

This map shows the geographic impact of Daisuke Sueta's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Daisuke Sueta with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Daisuke Sueta more than expected).

Fields of papers citing papers by Daisuke Sueta

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Daisuke Sueta. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Daisuke Sueta. The network helps show where Daisuke Sueta may publish in the future.

Co-authors

The 25 scholars most cited alongside Daisuke Sueta, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Daisuke Sueta Line = papers co-authored together Daisuke Sueta links everyone, so they are left out of the graph.

All Works

20 of 20 papers shown

Showing the 20 most-cited of 128 papers — load more, or switch the sort, to bring in the rest.

#Work
1
Glycemic control with empagliflozin, a novel selective SGLT2 inhibitor, ameliorates cardiovascular injury and cognitive dysfunction in obese and type 2 diabetic mice
Hit paper breakdown →
2014346
2 2011122
3 201192
4 201778
5 201376
6 201564
7 201662
8 201659
9 201955
10 201452
11 201347
12 201847
13 201446
14 201346
15 201644
16 201341
17 201736
18 202035
19 201733
20 201733

About Daisuke Sueta

Daisuke Sueta is a scholar working on Cardiology and Cardiovascular Medicine, Surgery, Radiology, Nuclear Medicine and Imaging, Molecular Biology and Internal Medicine, having authored 128 papers that have together received 2.3k indexed citations. Recurring topics across this work include Cardiac Imaging and Diagnostics (15 papers), Cardiovascular Function and Risk Factors (13 papers), Atrial Fibrillation Management and Outcomes (10 papers), Venous Thromboembolism Diagnosis and Management (9 papers), Chemotherapy-induced cardiotoxicity and mitigation (9 papers), Amyloidosis: Diagnosis, Treatment, Outcomes (9 papers), Coronary Interventions and Diagnostics (7 papers) and Heart Failure Treatment and Management (6 papers). The work is most often cited by research in Cardiology and Cardiovascular Medicine (782 citations), Neurology (231 citations), Endocrinology, Diabetes and Metabolism (433 citations), Internal Medicine (82 citations) and Nephrology (91 citations). Daisuke Sueta has collaborated with scholars based in Japan, United States and Israel. Frequent co-authors include Shokei Kim‐Mitsuyama, Nobutaka Koibuchi, Kensuke Toyama, Eiichiro Yamamoto, Kenichi Tsujita, Hisao Ogawa, Yu Hasegawa, Ken Uekawa, Koichi Kaikita and Seiji Hokimoto. Their work appears in journals such as International Journal of Cardiology, Journal of the American Heart Association, American Journal of Hypertension, ESC Heart Failure and European Heart Journal.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact